Empagliflozin Has Kidney Protective Effects in Acute Myocardial Infarction
By Elana Gotkine HealthDay Reporter
THURSDAY, June 26, 2025 -- Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with acute myocardial infarction (MI), according to a study published online June 13 in Nature Cardiovascular Research.
Rahul Aggarwal, M.D., from Harvard Medical School in Boston, and colleagues examined the cardiovascular-kidney effects and safety of empagliflozin in a secondary analysis of a multicenter, clinical trial involving 6,522 patients with acute MI and risk for heart failure who were randomly allocated to receive empagliflozin or placebo.
The researchers found that the mean estimated glomerular filtration rate at baseline was 76.1 mL/min/1.73 m2; longitudinal kidney function data were available for 1,152 treated patients from select countries. Compared with baseline, by 24 months, the estimated glomerular filtration rate was similar in the empagliflozin group, but decreased in the placebo group. Irrespective of kidney function, the total adverse events of heart failure or all-cause mortality were reduced with empagliflozin. Similar 30-day adverse event rates were seen by treatment group, which were consistent across baseline kidney function.
"Empagliflozin demonstrated beneficial kidney-protective effects, reduced heart failure outcomes and was safe to initiate soon after acute MI," the authors write. "The cardiovascular-kidney benefits and safety of empagliflozin were consistent irrespective of baseline kidney function."
Several authors disclosed ties to biopharmaceutical companies; the study was funded by the Boehringer Ingelheim and Eli Lilly and Company Alliance.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
Atopic Dermatitis May Be Linked to Increased Risk for CKD
TUESDAY, July 15, 2025 -- Atopic dermatitis (AD) was associated with an increased risk for chronic kidney disease (CKD) in an Asian population, according to a study published...
Exposure to Trihalomethanes Linked to Chronic Kidney Disease
TUESDAY, July 8, 2025 -- Exposure to trihalomethanes, especially brominated trihalomethanes, in residential community water supplies (CWS) is associated with an increased risk for...
Wildfire Smoke Exposure Increases Risk for Heart Failure
TUESDAY, July 8, 2025 -- Wildfire smoke exposure over time may increase the risk for heart failure, according to a study published in the July issue of the Journal of the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.